Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health and illness beliefs in adults with tuberculosis infection during the COVID-19 pandemic in the UK.
Kılıç A, Clarke AL, Moon Z, Hamada Y, Chan AHY, Rahman A, Layton C, Griffiths CJ, Zenner D, Powell E, Kunst H, Lipman M, Mandelbaum M, Papineni P, Tattersall T, Duong T, Abubakar I, Rangaka MX, Horne R. Kılıç A, et al. Among authors: layton c. Dialogues Health. 2023 Nov 29;4:100162. doi: 10.1016/j.dialog.2023.100162. eCollection 2024 Jun. Dialogues Health. 2023. PMID: 38516222 Free PMC article.
Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial.
Rangaka MX, Hamada Y, Duong T, Bern H, Calvert J, Francis M, Clarke AL, Ghanouni A, Layton C, Hack V, Owen-Powell E, Surey J, Sanders K, Booth HL, Crook A, Griffiths C, Horne R, Kunst H, Lipman M, Mandelbaum M, White PJ, Zenner D, Abubakar I. Rangaka MX, et al. Among authors: layton c. BMJ Open. 2022 Sep 6;12(9):e057717. doi: 10.1136/bmjopen-2021-057717. BMJ Open. 2022. PMID: 36691120 Free PMC article.
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.
Duong T, Brigden J, Simon Schaaf H, Garden F, Marais BJ, Anh Nguyen T, White IR, Gibb DM, Nhung NV, Martinson NA, Fairlie L, Martinez L, Layton C, Benedetti A, Marks GB, Turner RM, Seddon JA, Hesseling AC, Fox GJ. Duong T, et al. Among authors: layton c. NEJM Evid. 2025 Jan;4(1):EVIDoa2400190. doi: 10.1056/EVIDoa2400190. Epub 2024 Dec 18. NEJM Evid. 2025. PMID: 39693627
Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.
Hesseling AC, Purchase SE, Martinson NA, Fairlie L, Schaaf HS, Brigden J, Staples S, Gibb DM, Garcia-Prats A, Conradie F, McGowan C, Layton C, Batist E, Demers AM, Nyamathe S, Frigati L, Turner R, Duong T, Seddon JA. Hesseling AC, et al. Among authors: layton c. N Engl J Med. 2024 Dec 19;391(24):2315-2326. doi: 10.1056/NEJMoa2314318. N Engl J Med. 2024. PMID: 39693542 Clinical Trial.
Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
MacIsaac MB, Papaluca T, McDonald L, Craigie A, Edwards A, Layton C, Gibson A, Winter RJ, Iyer K, Sim A, Evans S, Kumaragama K, Howell J, Desmond P, Iser D, Scott N, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Holmes JA, Thompson AJ. MacIsaac MB, et al. Among authors: layton c. Clin Infect Dis. 2024 Sep 16:ciae471. doi: 10.1093/cid/ciae471. Online ahead of print. Clin Infect Dis. 2024. PMID: 39282957
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity.
Sheikh S, Munson T, Garvan G, Layton C, Sollee D, Cowdery C, Peterson A, Rothstein LS, Henson M, Gartner H, Ujhelyi M. Sheikh S, et al. Among authors: layton c. Drugs Real World Outcomes. 2024 Sep;11(3):377-388. doi: 10.1007/s40801-024-00435-0. Epub 2024 Jun 5. Drugs Real World Outcomes. 2024. PMID: 38839728 Free PMC article.
222 results